Pfizer and Wisconsin-based diagnostics firm, Exact Sciences, announced an agreement through 2021 to drive a DNA screening test for colorectal cancer through expanded sales and marketing efforts.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.